HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gerald D. Buckberg Jakob Vinten-Johansen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mizuno, A. Articles by Ignarro, L. J. Search for Related Content PubMed PubMed Citation Articles by Mizuno, A. Articles by Ignarro, L. J.

J Thorac Cardiovasc Surg 1997;113:379-389
© 1997 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

ENDOTHELIAL STUNNING AND MYOCYTE RECOVERY AFTER REPERFUSION OF JEOPARDIZED MUSCLE: A ROLE OF L-ARGININE BLOOD CARDIOPLEGIA

Rufus Baretti was supported in full by the Deutsche Forschungsgemeinschaft (German Research Foundation).

Received for publication May 22, 1996 revisions requested August 6, 1996; revisions received August 30, 1996; accepted for publication Sept. 9, 1996. Address for reprints: Gerald D. Buckberg, MD, UCLA School of Medicine, Division of Cardiothoracic Surgery, Room B2-375 CHS, 10833 Le Conte Ave., Los Angeles, CA 90095-1741.

Abstract

Ischemia and reperfusion may damage myocytes and endothelium in jeopardized hearts. This study tested whether (1) endothelial dysfunction (reduced nitric oxide release) exists despite good contractile performance and (2) supplementation of blood cardioplegic solution with nitric oxide precursor L-arginine augments nitric oxide and restores endothelial function. Among 30 Yorkshire-Duroc pigs, 6 received standard glutamate/aspartate blood cardioplegic solution without global ischemia. Twenty-four underwent 20 minutes of 37° C global ischemia. Six received normal blood reperfusion. In 18, the aortic clamp remained in place 30 more minutes and all received 3 infusions of blood cardioplegic solution. In 6, the blood cardioplegic solution was unaltered; in 6, the blood cardioplegic solution contained L-arginine (a nitric oxide precursor) at 2 mmol/L; in 6, the blood cardioplegic solution contained the nitric oxide synthase inhibitor L-nitro arginine methyl ester (L-NAME) at 1 mmol/L. Complete contractile and endothelial recovery occurred without ischemia. In jeopardized hearts, complete systolic recovery followed infusion of blood cardioplegic solution and of blood cardioplegic solution plus L-arginine. Conversely, contractility recovered approximately 40% after infusion of normal blood and blood cardioplegic solution plus L-NAME. Postischemic nitric oxide production fell 50% in the groups that received blood cardioplegic solution and blood cardioplegic solution plus L-NAME but was increased in the group that received blood cardioplegic solution L-arginine. In vivo endothelium-dependent vasodilator responses to acetylcholine recovered 75% ± 5% of baseline in the blood cardioplegic solution plus L-arginine group, but less than 20% of baseline in other jeopardized hearts. Endothelium-independent smooth muscle responses to sodium nitroprusside were relatively unaltered. Myeloperoxidase activity (neutrophil accumulation) was similar in the blood cardioplegic solution (without ischemia) and blood cardioplegic solution plus L-arginine groups (0.01 ± 0.002 vs 0.013 ± 0.003 µg/gm tissue). Myeloperoxidase activity was raised substantially to 0.033 ± 0.002 µg/gm after exposure to normal blood and to 0.025 ± 0.003 µg/gm after infusion of blood cardioplegic solution and was highest at 0.053 ± 0.01 µg/gm with exposure to blood cardioplegic solution plus L-NAME in jeopardized hearts. The discrepancy between contractile recovery and endothelial dysfunction in jeopardized muscle can be reversed by adding L-arginine to blood cardioplegic solution.

This article has been cited by other articles:

				A. Lerman and A. M. Zeiher Endothelial Function: Cardiac Events Circulation, January 25, 2005; 111(3): 363 - 368. [Full Text] [PDF]

				F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]

				S. Al-Ruzzeh, T. Athanasiou, S. George, B. E. Glenville, A. C. DeSouza, J. R. Pepper, and M. Amrani Is the use of cardiopulmonary bypass for multivessel coronary artery bypass surgery an independent predictor of operative mortality in patients with ischemic left ventricular dysfunction? Ann. Thorac. Surg., August 1, 2003; 76(2): 444 - 451. [Abstract] [Full Text] [PDF]

				M. Castella, G. D. Buckberg, and Z. Tan Blood cardioplegic protection in profoundly damaged hearts: role of Na+-H+ exchange inhibition during pretreatment or during controlled reperfusion supplementation Ann. Thorac. Surg., April 1, 2003; 75(4): 1238 - 1245. [Abstract] [Full Text] [PDF]

				G. D. Buckberg Endothelial and myocardial stunning J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S92 - 93. [Full Text] [PDF]

				M. Castella, G. D. Buckberg, Z. Tan, and L. J. Ignarro Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1113 - 1121. [Abstract] [Full Text]

				B. K. Podesser, J. Schirnhofer, O. Y. Bernecker, A. Kroner, M. Franz, S. Semsroth, B. Fellner, J. Neumuller, S. Hallstrom, and E. Wolner Optimizing Ischemia/Reperfusion in the Failing Rat Heart--Improved Myocardial Protection With Acute ACE Inhibition Circulation, September 24, 2002; 106(12_suppl_1): I-277 - I-283. [Abstract] [Full Text] [PDF]

				P. Korn, A. Kroner, J. Schirnhofer, S. Hallstrom, O. Bernecker, R. Mallinger, M. Franz, H. Gasser, E. Wolner, and B. K. Podesser Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 352 - 360. [Abstract] [Full Text] [PDF]

				E. Iraculis, A. Cequier, J. A. Gomez-Hospital, M. Sabate, J. Mauri, E. Fernandez-Nofrerias, B. Garcia del Blanco, F. Jara, and E. Esplugas Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis J. Am. Coll. Cardiol., July 17, 2002; 40(2): 257 - 265. [Abstract] [Full Text] [PDF]

				M. Carrier, M. Pellerin, L. P. Perrault, D. Bouchard, P. Page, N. Searle, and J. Lavoie Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial Ann. Thorac. Surg., March 1, 2002; 73(3): 837 - 841. [Abstract] [Full Text] [PDF]

				G. A. Kalweit, J. D. Schipke, E. Godehardt, and E. Gams Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1011 - 1018. [Abstract] [Full Text] [PDF]

				C. Burgdorf, D. Richardt, T. Kurz, M. Seyfarth, D. Jain, H. A. Katus, and G. Richardt Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning Cardiovasc Res, March 1, 2001; 49(4): 713 - 720. [Abstract] [Full Text] [PDF]

				G. D. Buckberg Editorial: Endothelial and myocardial stunning J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 640 - 641. [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, K. S. Bolling, S. Rahman, T. Wang, H. S. Maniar, S. M. Prasad, and M. N. Ilbawi The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection Ann. Thorac. Surg., September 1, 2000; 70(3): 756 - 764. [Abstract] [Full Text] [PDF]

				G. D. Buckberg Cardioplegic solutions: Unproved herbal approach versus tested scientificstudy J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 975 - 977. [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi DOSE DEPENDENCY OF L-ARGININE IN NEONATAL MYOCARDIAL PROTECTION: THE NITRIC OXIDE PARADOX J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 655 - 664. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi L-ARGININE, PROSTAGLANDIN, AND WHITE CELL FILTRATION EQUALLY IMPROVE MYOCARDIAL PROTECTION IN STRESSED NEONATAL HEARTS J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 665 - 673. [Abstract] [Full Text] [PDF]

				G. Szabo, S. Bahrle, N. Stumpf, K. Sonnenberg, E. Szabo, P. Pacher, T. Csont, R. Schulz, T. J. Dengler, L. Liaudet, et al. Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation Circ. Res., January 11, 2002; 90(1): 100 - 106. [Abstract] [Full Text] [PDF]